Evidence map›Paper›PMID 36463130›Full record

ArticleBMC public health2022

The determinants of immunization coverage among children aged between 12 and 35 months: a nationwide cross-sectional study in Lao People's Democratic Republic.

Yasunori Ichimura, Naoki Yanagisawa, Moe Moe Thandar, Chansay Pathammavong, Kongxay Phounphenghuk, Phonethipsavanh Nouanthong, Chankham Tengbriacheu, Bouaphane Khamphaphongphane, Lauren Elizabeth Franzel-Sassanpour, Tae Un Yang and 5 more

Abstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yasunori IchimuraBureau of International Health Cooperation, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, 162-8655, Japan. yichimura@it.ncgm.go.jp.
Naoki YanagisawaBureau of International Health Cooperation, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, 162-8655, Japan.
Moe Moe ThandarBureau of International Health Cooperation, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, 162-8655, Japan.
Chansay PathammavongNational Immunization Program, Ministry of Health, Simuang Road, Vientiane, Lao People's Democratic Republic.
Kongxay PhounphenghukNational Immunization Program, Ministry of Health, Simuang Road, Vientiane, Lao People's Democratic Republic.
Phonethipsavanh NouanthongInstitute Pasteur du Laos, National Immunization Technical Advisory Group, Ministry of Health, Samsenthai Road, Ban Kao-Gnot, Sisattanak district, Vientiane, Lao People's Democratic Republic.
Chankham TengbriacheuMother and Child Health Center, Ministry of Health, Simuang Road, Vientiane, Lao People's Democratic Republic.
Bouaphane KhamphaphongphaneNational Center Laboratory and Epidemiology, KM3 Thadeua road, Sisattanak District, Vientiane, Lao People's Democratic Republic.
Lauren Elizabeth Franzel-SassanpourVaccine-Preventable Diseases and Immunization section, World Health Organization Representative Office in the Lao People's Democratic Republic, 125 Saphanthong Road, Unit 5, Ban Saphangthongtai, Sisattanak District, Vientiane, Lao People's Democratic Republic.
Tae Un YangVaccine-Preventable Diseases and Immunization section, World Health Organization Representative Office in the Lao People's Democratic Republic, 125 Saphanthong Road, Unit 5, Ban Saphangthongtai, Sisattanak District, Vientiane, Lao People's Democratic Republic.
Hendrikus RaaijmakersHealth and Nutrition section, United Nations Children's Fund Lao People's Democratic Republic, KM3 Thadeua road, Sisattanak District, Vientiane, Lao People's Democratic Republic.
Tomomi OtaBureau of International Health Cooperation, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, 162-8655, Japan.
Kenichi KomadaBureau of International Health Cooperation, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, 162-8655, Japan.
Masahiko HachiyaBureau of International Health Cooperation, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, 162-8655, Japan.
Shinsuke MiyanoBureau of International Health Cooperation, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, 162-8655, Japan.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundImmunization is one of the most important public health interventions for reducing morbidity and mortality in children. However, factors contributing to low immunization coverage are not fully understood in the Lao People's Democratic Republic (Lao PDR). Therefore, this study aimed to identify factors associated with full immunization coverage among children between 12 and 35 months, providing up-to-date information for immunization programs in Lao PDR.

methodsWe analyzed the subpopulation of a nationwide cross-sectional survey using a multistage cluster sampling procedure to evaluate the measles and rubella seroepidemiology. In addition, we categorized children aged between 12 and 35 months into two groups: "fully immunized" children with a birth dose of Bacillus Calmette and Guérin vaccine, hepatitis B vaccine (Hep B), one and three doses for the measles-containing vaccine (MCV) and pentavalent vaccine and pneumococcal conjugate vaccine (PCV) and "partially immunized" children who missed any dose of vaccine. Immunization coverage was calculated as the ratio of "fully immunized" to the total. We compared the groups' demographic characteristics and health service utilization as independent variables. Multivariate logistic regression was used to assess the relationship between immunization coverage, various demographic factors, and health service utilization.

resultsOverall, 256 of the 416 targeted pairs were included in the analysis. In total, 67.6% of the children were fully immunized. Childbirth at hospitals or health facilities (adjusted odds ratio: 9.75, 95% confidence interval: 5.72-16.62, p < 0.001) was the predictor of full immunization coverage. The 83 children in the partially immunized groups were attributed to Hep B at birth (46, 55.4%), three doses of PCV (34, 41.0%), and the first dose of the MCV (27, 32.5%).

conclusionOur study elucidated that the immunization status among children aged between 12 and 35 months in Lao PDR is satisfactory in improving access to healthcare by strengthening communication with residents regarding health service utilization, and expanding mobile outreach services may play a pivotal role in this endeavor. Further research is warranted to evaluate efforts to increase immunization coverage and target populations with limited access to healthcare.

Indexed as

MeaslesViral VaccinesChildChild, PreschoolCross-Sectional StudiesFemaleHumansInfantInfant, NewbornLaosMeasles VaccinePregnancySeroepidemiologic StudiesVaccination CoverageVaccines, ConjugateMeasles VaccineVaccines, ConjugateViral VaccinesCross-sectional studyExtended program on immunization (EPI)Full immunizationImmunization coverageLao People’s Democratic Republic

Identifiers

PMID36463130
PMCPMC9719255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.